Votrient Approved for Soft Tissue Sarcoma
Federal Practitioner. 2012 June;29(6):e2
June 1, 2012|Federal Practitioner
Author and Disclosure Information
Votrient (pazopanib), a once-a-day pill, has been approved for soft tissue sarcoma in patients who have previously received chemotherapy.
